Destination

Houston Travel Vaccines

Travel Brief
Houston Texas is home to University of Houston, NASA and Rice University
May 15 • 12:22 pm CDT
Led by a team from the U.S. Centers for Disease Control and Prevention (CDC), the findings from a study published in the Journal of Infectious Diseases demonstrated the feasibility of assessing seasonal influenza vaccine effectiveness (VE)... READ →
May 9 • 5:47 am CDT
With about 8 million cases annually, gonorrhea is one of the most common sexually transmitted infections, without a U.S. FDA-approved vaccine available. However, another study has concluded that leveraging an existing vaccine provides some cross-protection against... READ →
May 5 • 11:51 am CDT
Over the past Respiratory syncytial virus (RSV) seasons, infants have been offered a new monoclonal antibody to protect them from lower respiratory tract infections (LRTIs). A cost-effectiveness analysis , published on May 3, 2025, estimates the... READ →

Houston, Texas Travel Vaccines May 2025

When planning a business trip or vacation, certified travel vaccination experts in Houston, Texas, are available for pre-and post-travel advice and services. As of May 14, 2025, travel vaccination services for yellow fever, polio, measles, dengue, cholera, and other travel-related diseases are available in Houston, Katy (77494), Woodlands (77345), Galveston (77550), Pasadena (77015), League City (77058), and Sugarland (77496).

As of May 2025, the U.S. Centers for Disease Control and Prevention (CDC) suggests scheduling a travel vaccination appointment at least one month before departing.

Yellow Fever Vaccines in Houston, Texas

Yellow fever vaccination services are available in Houston clinics and pharmacies. The YF-Vax® single-dose Yellow Fever vaccine is available in 2025. This vaccine generates maximum immunity after ten days. Known as the 'yellow card,' the International Certificate of Vaccination or Prophylaxis (ICVP) is available following vaccination at certified yellow fever vaccination centers. As of 2025, the WHO published an updated Country List to identify which countries require an ICVP to enter. 

Travel Vaccines 2025

Travel vaccinations include but are not limited to the following vaccines:

Cholera - The cholera vaccine has constrained availability worldwide, but is available in the U.S.

Dengue—The Dengvaxia vaccine is no longer available in the U.S. The Qdenga vaccine is authorized in several countries but not in the U.S.

Hajj and Umrah - Several vaccinations are required to enter the Kingdom of Saudi Arabia.

Malaria - Two malaria vaccines are available in Africa in 2025, but not in the U.S.

Measle—The  MMR, Proquad, and Priorix vaccines are available in the U.S. In 2025, measles cases were reported in Harris County, western Texas, and Travis County.

Mpox - The Jynneos vaccine is a U.S. FDA-authorized vaccine. The Houston Health Department offers free mpox vaccines.

Polio vaccines—The IPOL vaccine is advised for international travelers visiting at-risk countries. The nOPV2 polio vaccine is unavailable in the U.S. but has been administered over 1 billion times globally.

Tuberculosis - Merck's Tice BCG vaccine is approved, but availability is limited in Houston. Recent data indicate tuberculosis rates are accelerating in Houston,

Typhoid - Both the Vivotif and Typbar TCV vaccines are available in 2025.

Urinary Tract Vaccine - The Uromune (MV140) recurrent Urinary Tract Infection (rUTI) vaccine is not offered in the U.S. but will be available in Mexico and England in 2025. International appointment requests can be made using this link.

Vaccine Travel Alerts For Houston, Texas.

As of 2025, neither the U.S. CDC, the CDC Health Advisory Network, nor the U.S. Department of State had issued a Travel Advisory for Houston, Texas. However, the Houston Health Department, Harris County Public Health (HCPH), and the Texas Department of State Health Services announced that residents should take precautions against malaria and measles.

Travel Vaccine News

Vax-Before-Travel publishes breaking vaccine news in 2025.

Last reviewed
May 15, 2025